SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-018760
Filing Date
2021-03-30
Accepted
2021-03-30 17:12:55
Documents
15
Period of Report
2021-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea138608-8k_cleverleaves.htm   iXBRL 8-K 30414
2 PRESS RELEASE DATED MARCH 30, 2021 - CLEVER LEAVES REPORTS FOURTH QUARTER AND FU ea138608ex99-1_cleverleaves.htm EX-99.1 143320
3 GRAPHIC ex99-1_001.jpg GRAPHIC 1946
  Complete submission text file 0001213900-21-018760.txt   420863

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE clvr-20210330.xsd EX-101.SCH 3977
5 XBRL DEFINITION FILE clvr-20210330_def.xml EX-101.DEF 28343
6 XBRL LABEL FILE clvr-20210330_lab.xml EX-101.LAB 37324
7 XBRL PRESENTATION FILE clvr-20210330_pre.xml EX-101.PRE 26968
8 EXTRACTED XBRL INSTANCE DOCUMENT ea138608-8k_cleverleaves_htm.xml XML 5755
Mailing Address 20TH FLOOR 250 HOWE STREET VANCOUVER A1 V6C 3R8
Business Address 489 FIFTH AVENUE 27TH FLOOR NEW YORK NY 10017 646-880-4382
Clever Leaves Holdings Inc. (Filer) CIK: 0001819615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39820 | Film No.: 21787769
SIC: 2834 Pharmaceutical Preparations